Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 801–808 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Bayer AG ADR Factor XIa (FXIa) and Asundexian - (OCEANIC-STROKE) Acute non-cardioembolic stroke or high risk transient ischemic attack (TIA) Phase 3 Data Released Oral Neurology
Beam Therapeutics Inc. Ristoglogene autogetemcel (risto-cel, formerly known as BEAM-101) - (BEACON) Sickle cell disease BLA Filing Data Released Intravenous infusion Hematology
BeiGene Ltd. Tislelizumab Squamous non-small cell lung cancer (NSCLC) Phase 3 Intravenous Oncology
BeiGene Ltd. BRUKINSA (zanubrutinib) - (Max Foundation trial) Chronic lymphocytic leukemia (CLL) Phase 2 Enrollment Initiation Oral Oncology
BeiGene Ltd. DKN-01 plus pembrolizumab Endometrial cancer Phase 2 Trial Planned intravenous Oncology
BeiGene Ltd. Ociperlimab (OCI) + Tislelizumab (TIS) - (AdvanTIG-203) Esophageal Squamous Cell Carcinoma (ESCC) Phase 2 Intravenous Oncology
BeiGene Ltd. Tislelizumab Squamous non-small cell lung cancer (NSCLC) Phase 3 Intravenous Oncology
BeiGene Ltd. Tislelizumab - (RATIONALE 309) Nasopharyngeal cancer (RM-NPC) Phase 3 Intravenous Oncology